No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, vein detained needles, nebulizer sets, and vacuum blood collection tubes; over-the-counter products; and APIs to treat cardiovascular, IPF, ED, anti-tumor, anti-emetic, antibiotic, VB12, anti-rheumatoid arthritis, multiple sclerosis, anti-schizophrenia, CKD and anti-anemia, polypeptide, and other indications. It also provides ambroxol hydrochloride, potassium chloride, sodium chloride, magnesium sulfate, glucose, sterile water, sodium bicarbonate, lidocaine hydrochloride, vitamin B6, ribavirin, ceftazidime, 5% glucose, and ceftriaxone sodium injections. In addition, the company engages in investment; import and export; enterprise management; logistics and transportation; business services; agricultural non-staple food processing; production and sale of pharmaceutical intermediates; research and development of bio-based materials technology; Internet and related services; crop planting; professional technical; biotechnology extension; socio-economic consultation; technology promotion; medical research and testing exhibition; general cargo road transport; ecological protection and environmental management; and wholesale and retail. It exports its products to Japan. The company was formerly known as Sichuan Kelun Pharmaceutical Factory Co., Ltd and changed its name to Sichuan Kelun Pharmaceutical Co., Ltd. in August 2003. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. operates as a subsidiary of Sichuan Kelun Industry Group CO., LTD.
www.kelun.comNo one on the platform currently holds 002422.SZ.
No tracked institution reports a position in 002422.SZ as of their last filing.
No one on the platform has traded 002422.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 6.8% | 10.0% | 7.6% | — | — | — |
| Rev. Growth % | -15.9% | 2.2% | ||||
| Profit Margin % | 9.3% | 9.9% | 8.1% | |||
| Free Cash Flow Margin % | 6.5% | 11.7% | 8.0% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $19.7B | +9.1% | $1.24 | $1.20–$1.29 | — | 5 |
| 2027 | $22.5B | +14.3% | $1.57 | $1.46–$1.76 | — | 7 |
| 2028 | $25.8B | +14.6% | $1.99 | $1.84–$2.21 | — | 4 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 1 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-26 | $0.32 | $0.37 | +14.5% |
| 2026-04-28 | $0.37 | $0.30 | -18.1% |
| 2026-04-02 | $0.36 | $0.31 | -14.1% |
| 2025-10-31 | $0.45 | $0.13 | -72.4% |
| 2025-08-28 | $0.34 | $0.26 | -23.5% |
| 2025-04-29 | $0.58 | $0.37 | -36.2% |
| 2025-04-23 | $0.41 | $0.29 | -29.3% |
| 2024-10-28 | $0.46 | $0.42 | -8.7% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 002422.SZSichuan Kelun Pharmaceutical Co., Ltd. Class A | $40.65 | -1.76% | $64.7B | — |
| 000423.SZDong-E-E-Jiao Co.,Ltd. | $46.11 | -0.77% | $29.5B | — |
| 000538.SZYunnan Baiyao Group Co.,Ltd | $50.74 | -0.04% | $90.5B | — |
| 000963.SZHuadong Medicine Co., Ltd | $26.19 | -1.02% | $45.9B | — |
| 002007.SZHualan Biological Engineering Inc. |
| $12.86 |
| -1.61% |
| $23.5B |
| — |
| 002294.SZShenzhen Salubris Pharmaceuticals Co., Ltd. | $29.60 | -2.15% | $33.0B | — |
| 4151.TKyowa Kirin Co., Ltd. | $2228.00 | -0.58% | $1.17T | — |
Source: Financial Modeling Prep · peers by sector/industry